Press release
2025 Antisense & RNAi Therapeutics Industry Trends Report: Long-Term Outlook Through 2034
Antisense & RNAi Therapeutics
How Large Will the Antisense & RNAi Therapeutics Market Size By 2025?
There has been a swift expansion in the antisense & RNAi therapeutics market in the past few years. The market value, which was $1.75 billion in 2024, is predicted to escalate to $1.94 billion in 2025, presenting an impressive compound annual growth rate (CAGR) of 11.2%. The substantial growth witnessed in the historic time frame can be credited to the surge in funding, technological advancements, increase in healthcare spending, acceleration in the growth of the elderly populace, and upward economic trends in growing markets.
How Big Is the Antisense & RNAi Therapeutics Market Size Expected to Grow by 2029?
In the coming years, the antisense & RNAi therapeutics market is projected to experience swift expansion, reaching $3.18 billion by 2029 with a compound annual growth rate (CAGR) of 13.1%. The predicted growth during the forecast period can be ascribed to improved access to healthcare, increasing cancer prevalence, and the rising demand for antisense and RNAi therapeutics due to the COVID-19 pandemic. The forecast period also sees major trends such as concentrated efforts on research and development of RNA therapeutics for rare diseases, utilization of nanoparticles, and the development of enhanced antisense and RNAi therapeutics. Collaborations with other firms for product innovation and revenue generation will also be a key trend.
View the full report here:
https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report
Which Key Market Drivers Powering Antisense & RNAi Therapeutics Market Expansion and Growth?
The antisense & RNAi therapeutics market is expected to see increased demand due to a surge in the incidence of coronary artery diseases, neurodegenerative illnesses, and infectious ailments. Gene silencing techniques, such as RNA interference and antisense oligonucleotides, are employed to fix mutant genes and manage a variety of neurodegenerative conditions. As an illustration, a report from the American Heart Association, a renowned US organization, indicated that as of January 2024, the age-adjusted death rate from cardiovascular diseases spiked to 233.3 per 100,000, marking a 4.0% increase from the preceding year. Consequently, the rise in the occurrence of various neurodegenerative and infectious diseases is anticipated to fuel the expansion of the antisense & RNAi therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Antisense & RNAi Therapeutics Market?
Key players in the antisense & RNAi therapeutics market are employing strategic moves such as forming collaborations and partnerships to keep their footing in a progressively competitive environment. This strategic cooperation is a business tactic that sees multiple businesses collaborate to reach a shared purpose or aim. For instance, in January 2023, US-based Orbit Discovery Limited, a firm that provides services for the discovery of peptides, established a partnership with SanegeneBio Inc., a UK-based firm known for developing unique RNAi-based medicines. The aim of this partnership is to identify tissue-specific distributions of therapeutics for efficient gene knockdown, as well as to cultivate a collection of enhanced RNAi therapeutics. The partnership will include hit identification and cell-based internalization studies, and SanegeneBio will have the choice to further develop hits that derive from the screening actions. These developments will utilize Orbit's exclusive technology for swift peptide lead discovery. The distinctive peptide display engine of Orbit Discovery facilitates the examination of large peptide libraries, thus providing quicker detection times for appropriate peptide leads relying on affinity and functional screens.
What Are the Emerging Segments in the Antisense & RNAi Therapeutics Market?
The antisense & RNAi therapeutics market covered in this report is segmented -
1) By Technology: RNA Interference, Antisense RNA
2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics
2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3389&type=smp
Who Are the Global Leaders in the Antisense & RNAi Therapeutics Market?
Major companies operating in the antisense & RNAi therapeutics market include Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics, Dynacure, CN Bio Innovations, Sarepta Therapeutics, Mallinckrodt, Regeneron Pharmaceuticals Inc., Alcyone Lifesciences Inc., Bio-Path Holdings Inc, Calando Pharmaceuticals, Enzon Pharmaceuticals Inc, Celnova Pharma, Pfizer Inc., Taiba Pharma, Gen Ilaç ve Saglik Ürünleri A.S., Egypt Otsuka Pharmaceutical
Which are the Top Profitable Regional Markets for the Antisense & RNAi Therapeutics Industry?
North America was the largest region in the antisense & RNAi therapeutics market in 2024. The regions covered in the antisense & RNAi therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3389
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025 Antisense & RNAi Therapeutics Industry Trends Report: Long-Term Outlook Through 2034 here
News-ID: 4102985 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
